The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty
- 1 December 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 148 (3), 200-202
- https://doi.org/10.1007/bf00441401
Abstract
We have treated seven pubertal children, five (three female, two male) with growth hormone deficiency and two (one female, one male) with constitutional short stature with intranasal (D-Serine6) gonadotrophin releasing hormone (GnRH) analogue (Buserelin) for a mean of 0.84 years (range, 0.5–1.3). Treatment was successful in arresting pubertal development but there was no improvement in final height prognosis.This publication has 8 references indexed in Scilit:
- Growth, Growth Hormone and Sex Steroid Secretion in Girls with Central Precocious Puberty Treated with a Gonadotrophin Releasing Hormone (GnRH) AnalogueActa Paediatrica, 1988
- THE MECHANISM OF THE ADOLESCENT GROWTH SPURT INDUCED BY LOW DOSE PULSATILE GnRH TREATMENTClinical Endocrinology, 1988
- TREATMENT OF PRECOCIOUS PUBERTY IN GIRLS WITH INTRANASAL LHRH AGONIST (BUSERELIN)Pediatric Research, 1986
- THE TREATMENT OF CENTRAL PRECOCIOUS PUBERTY USING AN INTRANASAL LHRH ANALOGUE (BUSERELIN)Clinical Endocrinology, 1985
- Precocious Puberty Secondary to Cranial Irradiation for Tumors Distant from the Hypothalamo-Pituitary AreaHormone Research, 1985
- Long-Term Treatment of Central Precocious Puberty with a Long-Acting Analogue of Luteinizing Hormone-Releasing HormoneNew England Journal of Medicine, 1983
- Results of Intermittent Treatment of Growth Hormone Deficiency with Human Growth HormoneJournal of Clinical Endocrinology & Metabolism, 1977
- The Effect of Puberty on Growth Hormone Secretion in Boys with Short Stature and Delayed AdolescenceAustralian and New Zealand Journal of Medicine, 1971